<DOC>
	<DOCNO>NCT00163436</DOCNO>
	<brief_summary>The aim present study investigate efficacy safety ciclesonide lung function safety . Ciclesonide inhale one dose level daily , use inhaler device without spacer . The study duration consist baseline period ( 1 3 week ) treatment period ( 12 week ) .</brief_summary>
	<brief_title>Efficacy Safety Ciclesonide Administered With Without Different Spacers Patients With Asthma ( 12 75 ) ( BY9010/M1-145 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Written inform consent History persistent bronchial asthma least 6 month Good health exception asthma Main Concomitant severe disease disease contraindication use inhaled steroid Smoking history â‰¥10 cigarette pack year Pregnancy Intention become pregnant Breast feeding Lack safe contraception Previous enrolment current study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
</DOC>